Connect your AI

ClearPoint Neuro CLPT Raw materials

Raw materials at other companies

AbbottABT

$1.72B+2.1%

Neuropace, Inc.NPCE

$6.11M+44.9%

ITG

Integer HoldingsITGR

$104.08M-5.0%

Boston ScientificBSX

——

MedtronicMDT

——

PenumbraPEN

——

Other financials

Income statement

Revenue$12.1M+42.9%

Gross profit$7.8M+51.1%

Operating income-$8.5M-37.6%

Net income-$9.6M-58.5%

EPS (diluted)-$0.32-45.5%

Balance sheet

Cash & equivalents$36.5M+195%

Total debt$63.6M+1,750%

Total equity$18.8M-5.7%

Total assets$93.4M+211%

Cash flow

Operating cash flow-$8.0M-29.1%

CapEx$645.0K+252%

Free cash flow-$8.6M-35.5%

Valuation

Market cap$538.61M+69.2%

Enterprise value$565.68M+82.9%

P/S13.3×+3.4×

Profitability

Gross margin62.3%+1.1pp

Operating margin-65.2%-1.9pp

Net margin-71.6%+8.8pp

FCF margin-65.7%+269pp

Returns & leverage

Return on equity-149.7%+4,074pp

Debt / equity3.4×+3.2×

Current ratio5.8×+2.3×

Where this comes from

Reported directly by ClearPoint Neuro in its filing.

Tagged under the XBRL concept us-gaap:InventoryWorkInProcessAndRawMaterials.

The official record: ClearPoint Neuro’s 10-Q, filed May 13, 2026, on SEC EDGAR. View the filing →

Ask your AI about ClearPoint Neuro's raw materials.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI

Harbor at dusk

Questions, answered.

What is ClearPoint Neuro's raw materials?: ClearPoint Neuro (CLPT) reported raw materials of $6.72M in Q1 2026.
What does raw materials mean?: Unprocessed materials and components purchased for use in manufacturing, valued at cost.